Characterization of pulmonary T cell response to helper-dependent adenoviral vectors following intranasal delivery

Journal of Immunology

Volumn 180, Issue 6, 2008, Pages 4098-4108

  Kushwah, Rahul ^a,b   Cao, Huibi ^a   Hu, Jim ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HELPER CELL; LOW DRUG DOSE; LUNG ALVEOLUS CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADENOVIRUS; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CLASSIFICATION; CYTOLOGY; GENE VECTOR; GENETICS; HELPER VIRUS; IMMUNOLOGY; INNATE IMMUNITY; INTRANASAL DRUG ADMINISTRATION; LUNG; METABOLISM; T LYMPHOCYTE SUBPOPULATION; VIROLOGY; VIRUS INFECTION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADMINISTRATION, INTRANASAL; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; GENETIC VECTORS; HELPER VIRUSES; IMMUNITY, NATURAL; LUNG; MICE; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS;

EID: 44849119954     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.6.4098     Document Type: Article

References (46)

1. Campos, S. K., and M. A. Barry. 2007. Current advances and future challenges in Adenoviral vector biology and targeting. Curr. Gene Ther. 7: 189-204.
2. Flotte, T. R., P. Ng, D. E. Dylla, P. B. McCray, Jr., G. Wang, J. K. Kolls, and J. Hu. 2007. Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis. Mol. Ther. 15: 229-241.
3. Brunetti-Pierri, N., and P. Ng. 2006. Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Curr. Opin. Mol. Ther. 8: 446-454.
4. Kushwah, R., J. R. Oliver, H. Cao, and J. Hu. 2007. Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways. Gene Ther. 14: 1243-1248.
5. Kushwah, R., H. Cao, and J. Hu. 2007. Potential of helper-dependent adenoviral vectors in modulating airway innate immunity. Cell. Mol. Immunol. 4: 81-89.
6. Alba, R., A. Bosch, and M. Chillon. 2005. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 12 (Suppl. 1): S18-S27.
7. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166.
8. Liu, Q., and D. A. Muruve. 2003. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10: 935-940.
9. Koehler, D. R., B. Martin, M. Corey, D. Palmer, P. Ng, A. K. Tanswell, and J. Hu. 2006. Readministration of helper-dependent adenovirus to mouse lung. Gene Ther. 13: 773-780.
10. Morral, N., W. O'Neal, K. Rice, M. Leland, J. Kaplan, P. A. Piedra, H. Zhou, R. J. Parks, R. Velji, E. Aguilar-Cordova, et al. 1999. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96: 12816-12821.
11. Zaiss, A. K., and D. A. Muruve. 2005. Immune responses to adeno-associated virus vectors. Curr. Gene Ther. 5: 323-331.
12. Wilson, J. 2007. Humility and clinical trials. Mol. Ther. 15: 1571-1573.
13. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
14. Lambrecht, B. N., B. Salomon, D. Klatzmann, and R. A. Pauwels. 1998. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J. Immunol. 160: 4090-4097.
15. Upham, J. W. 2003. The role of dendritic cells in immune regulation and allergic airway inflammation. Respirology 8: 140-148.
16. Lambrecht, B. N., R. A. Pauwels, and B. Fazekas De St. Groth. 2000. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J. Immunol. 164: 2937-2946.
17. Lambrecht, B. N., M. De Veerman, A. J. Coyle, J. C. Gutierrez-Ramos, K. Thielemans, and R. A. Pauwels. 2000. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106: 551-559.
18. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
19. Koehler, D. R., U. Sajjan, Y. H. Chow, B. Martin, G. Kent, A. K. Tanswell, C. McKerlie, J. F. Forstner, and J. Hu. 2003. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc. Natl. Acad. Sci. USA 100: 15364-15369.
20. Chen, J. C., M. L. Chang, and M. O. Muench. 2003. A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J. Immunol. Methods 279: 123-133.
21. Carayon, P., and A. Bord. 1992. Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J. Immunol. Methods 147: 225-230.
22. Grayson, M. H., M. S. Ramos, M. M. Rohlfing, R. Kitchens, H. D. Wang, A. Gould, E. Agapov, and M. J. Holtzman. 2007. Controls for lung dendritic cell maturation and migration during respiratory viral infection. J. Immunol. 179: 1438-1448.
23. Smit, J. J., B. D. Rudd, and N. W. Lukacs. 2006. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203: 1153-1159.
24. Santini, S. M., T. Di Pucchio, C. Lapenta, S. Parlato, M. Logozzi, and F. Belardelli. 2002. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 22: 1071-1080.
25. Legge, K. L., and T. J. Braciale. 2003. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18: 265-277.
26. Manno, C. S., G. F. Pierce, V. R. Arruda, B. Glader, M. Ragni, J. J. Rasko, M. C. Ozelo, K. Hoots, P. Blatt, B. Konkle, et al. 2006. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12: 342-347.
27. + T cells. Blood 104: 2432-2440.
28. Belz, G. T., C. M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F. R. Carbone, and W. R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101: 8670-8675.
29. Allan, R. S., J. Waithman, S. Bedoui, C. M. Jones, J. A. Villadangos, Y. Zhan, A. M. Lew, K. Shortman, W. R. Heath, and F. R. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162.
30. + T cells. J. Immunol. 178: 6861-6866.
31. Sant, A. J., F. A. Chaves, S. A. Jenks, K. A. Richards, P. Menges, J. M. Weaver, and C. A. Lazarski. 2005. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 207: 261-278.
32. Lazarski, C. A., F. A. Chaves, S. A. Jenks, S. Wu, K. A. Richards, J. M. Weaver, and A. J. Sant. 2005. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Immunity 23: 29-40.
33. Hikono, H., J. E. Kohlmeier, K. H. Ely, I. Scott, A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2006. T-cell memory and recall responses to respiratory virus infections. Immunol. Rev. 211: 119-132.
34. + T cells during primary pulmonary influenza virus infection. J. Immunol. 174: 5332-5340.
35. + T cells during pulmonary influenza virus infection. J. Immunol. 173: 1209-1218.
36. Zhu, J., X. Huang, and Y. Yang. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J. Virol. 81: 3170-3180.
37. Vosters, O., J. Neve, D. De Wit, F. Willems, M. Goldman, and V. Verhasselt. 2003. Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory t cells. Transplantation 75: 383-389.
38. Thiele, A. T., T. L. Sumpter, J. A. Walker, Q. Xu, C. H. Chang, R. L. Bacallao, R. Kher, and D. S. Wilkes. 2006. Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2. J. Virol. 80: 1826-1836.
39. Rawle, F. C., A. E. Tollefson, W. S. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus cytotoxic T lymphocytes: inhibition of lysis by E3 gp19K but not E3 14.7K. J. Immunol. 143: 2031-2037.
40. Sparer, T. E., R. A. Tripp, D. L. Dillehay, T. W. Hermiston, W. S. Wold, and L. R. Gooding. 1996. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70: 2431-2439.
41. Sa-Nunes, A., A. Bafica, D. A. Lucas, T. P. Conrads, T. D. Veenstra, J. F. Andersen, T. N. Mather, J. M. Ribeiro, and I. M. Francischetti. 2007. Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J. Immunol. 179: 1497-1505.
42. Straube, C., R. Wehner, M. Wendisch, M. Bornhauser, M. Bachmann, E. P. Rieber, and M. Schmitz. 2007. Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells. Leukemia 21: 1464-1471.
43. Zeyda, M., B. M. Kirsch, R. Geyeregger, K. M. Stuhlmeier, G. J. Zlabinger, W. H. Horl, M. D. Saemann, and T. M. Stulnig. 2005. Inhibition of human dendritic cell maturation and function by the novel immunosuppressant FK778. Transplantation 80: 1105-1111.
44. Nishiyama, S., N. Manabe, Y. Kubota, H. Ohnishi, A. Kitanaka, M. Tokuda, T. Taminato, T. Ishida, J. Takahara, and T. Tanaka. 2005. Cyclosporin A inhibits the early phase of NF-κB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells. Int. Immunopharmacol. 5: 699-710.
45. Jooss, K., L. A. Turka, and J. M. Wilson. 1998. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther. 5: 309-319.
46. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70: 6370-6377.